Clinical Trials Browser

DNA Virus Infections, Infections, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial, Papilloma, Pathologic Processes, Recurrence, Respiratory Tract Diseases, Respiratory Tract Infections, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Disease Attributes, Papillomavirus Infections

NCT03036930 2026-04-13

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections

NCT07217145 2026-04-07

PREVENT HPV -Related Cancers Trial

Phase 3 Active not recruiting

1,455 enrolled

Behavior, Communication, Neoplasms, Patient Acceptance of Health Care, Papillomavirus Infections

NCT01898494 2026-04-01

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Phase 2 Active not recruiting

519 enrolled 16 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms, Papillomavirus Infections

Clinical Trials

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

PREVENT HPV -Related Cancers Trial

Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer

Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary Care

Self-TI

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging

Promoting HPV Vaccination Among Young Adults in Texas

APOSY

PARENT

QoLATI

LMI-001-A-S03

LMI-001-A-S02

Game-Based Intervention to Promote HPV Vaccination

ULACNet-202

Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement

Add-Vacc

ESCUDDO

Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

anal HSIL HIV-

9vHPV-BCG

V503-069

AI-DSS

Intradermal, Fractional Dose of HPV Vaccines:

Immunogenicity of Fractional Dose of the HPV Vaccines

V503-049

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052)

9-VPH-MVIH

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years

A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

V503-023

V503-071